FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs

FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs

U.S. Food and Drug Administration Commissioner Marty Makary speaks during a press conference alongside U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., and Centers for Medicare & Medicaid Services Administrator Mehmet Oz, discussing administration plans to lower drug costs, at the Department of Health and Human Services in Washington, D.C., U.S., Oct….

Read More